92 related articles for article (PubMed ID: 2459279)
1. Mechanism of antineuroblastoma activity of deferoxamine in vitro.
Blatt J; Taylor SR; Stitely S
J Lab Clin Med; 1988 Oct; 112(4):433-6. PubMed ID: 2459279
[TBL] [Abstract][Full Text] [Related]
2. Antineuroblastoma activity of desferoxamine in human cell lines.
Blatt J; Stitely S
Cancer Res; 1987 Apr; 47(7):1749-50. PubMed ID: 3815370
[TBL] [Abstract][Full Text] [Related]
3. Comparison of activity of deferoxamine with that of oral iron chelators against human neuroblastoma cell lines.
Blatt J; Taylor SR; Kontoghiorghes GJ
Cancer Res; 1989 Jun; 49(11):2925-7. PubMed ID: 2720651
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.
Brodie C; Siriwardana G; Lucas J; Schleicher R; Terada N; Szepesi A; Gelfand E; Seligman P
Cancer Res; 1993 Sep; 53(17):3968-75. PubMed ID: 8358725
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines.
Hoyes KP; Hider RC; Porter JB
Cancer Res; 1992 Sep; 52(17):4591-9. PubMed ID: 1511427
[TBL] [Abstract][Full Text] [Related]
6. Modulation of transferrin receptor expression by inhibitors of nucleic acid synthesis.
Hedley D; Rugg C; Musgrove E; Taylor I
J Cell Physiol; 1985 Jul; 124(1):61-6. PubMed ID: 2413049
[TBL] [Abstract][Full Text] [Related]
7. Deferoxamine and human neuroblastoma and primitive neuroectodermal tumor cell lines.
Helson C; Helson L
Anticancer Res; 1992; 12(2):481-3. PubMed ID: 1580565
[TBL] [Abstract][Full Text] [Related]
8. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
Richardson DR; Ponka P
J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
[TBL] [Abstract][Full Text] [Related]
9. Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma.
Brard L; Granai CO; Swamy N
Gynecol Oncol; 2006 Jan; 100(1):116-27. PubMed ID: 16203029
[TBL] [Abstract][Full Text] [Related]
10. Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells.
Kulp KS; Vulliet PR
Toxicol Appl Pharmacol; 1996 Aug; 139(2):356-64. PubMed ID: 8806853
[TBL] [Abstract][Full Text] [Related]
11. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
Chaston TB; Lovejoy DB; Watts RN; Richardson DR
Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
[TBL] [Abstract][Full Text] [Related]
12. Antileukemic effects of deferoxamine on human myeloid leukemia cell lines.
Becton DL; Roberts B
Cancer Res; 1989 Sep; 49(17):4809-12. PubMed ID: 2758414
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
14. Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro.
Schaider H; Haberkorn U; Stöhr M; Berger MR
Anticancer Res; 1995; 15(6B):2501-9. PubMed ID: 8669814
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity.
Kemp JD; Thorson JA; Stewart BC; Naumann PW
Cancer Res; 1992 Aug; 52(15):4144-8. PubMed ID: 1638529
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle effects of CC-1065.
Bhuyan BK; Crampton SL; Adams EG
Cancer Res; 1983 Sep; 43(9):4227-32. PubMed ID: 6871861
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of repeated exposure of human neuroblastoma cell lines to deferoxamine.
Helson L
Anticancer Res; 1991; 11(1):409-10. PubMed ID: 2018378
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis.
Maltese WA; Sheridan KM
J Cell Physiol; 1985 Dec; 125(3):540-58. PubMed ID: 3851809
[TBL] [Abstract][Full Text] [Related]
20. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
